New device aims to limit heart damage during heart attacks
NCT ID NCT04969471
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called enVast that removes blood clots from heart arteries during a severe heart attack (STEMI). About 148 adults with large clots will either get standard care or standard care plus the enVast device. The goal is to see if the device reduces the size of heart muscle damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
enVast coronary thrombectomy system (a device to remove blood clots from heart arteries)
What this could lead to
If successful, this device could reduce heart muscle damage during a heart attack, potentially improving recovery and long-term heart function.
What could go wrong
This is a mid-stage trial with 148 participants, so results may not apply to all patients. The device may not work better than standard treatment and carries risks like vessel injury or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEGMENT ELEVATION MYOCARDIAL INFARCTION (STEMI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Cardiocentro Ticino
Lugano, Switzerland